GB8808125D0
(en )
1988-05-11
New uses of dopamine receptor agonists
GB8611396D0
(en )
1986-06-18
Determination of thermophysical properties
GB2192541B
(en )
1990-05-02
New use of bromocriptine
PT83076A
(en )
1986-08-01
Dopamine-beta-hydroxylase inhibitors
GB2205745B
(en )
1990-09-19
Use of dioxopiperidine derivatives as analgesics
PT83628B
(en )
1988-11-15
Dopamine-beta-hydroxylase inhibitors
GB8520980D0
(en )
1985-09-25
Probe
GB8628049D0
(en )
1986-12-31
Use of tetrahydrobenzothienylurea derivatives
AU93235S
(en )
1986-08-28
Tissue holder
ZA863388B
(en )
1987-12-30
New use of dopamine agonists
ZA883237B
(en )
1990-01-31
Use of dopaminereceptor agonists
GB8628827D0
(en )
1987-01-07
Application of wax
ZA864635B
(en )
1987-11-25
Use of retinoid
PH25219A
(en )
1991-03-27
New benzamide derivatives
GB8511623D0
(en )
1985-06-12
Heteroanalogs of imidazobenzodiazepines
GB8621146D0
(en )
1986-10-08
Holder
ZA868234B
(en )
1987-12-30
Dopamine-beta-hydroxylase inhibitors
ZA867343B
(en )
1987-05-27
Use of thienylamines as production-promoting agents,new thienylamine
FR2582304B1
(en )
1989-06-02
SALT OF 5-OXOPROLINE AND 6-PIPERIDINO-2,4-DIAMINOPYRIMIDINE-3-OXIDE AND COMPOSITIONS FOR COSMETIC-DERMATOLOGICAL USE CONTAINING THE SAME
PT81973A
(en )
1986-03-01
Dopamine-beta-hydroxylase inhibitors
ZA889365B
(en )
1990-08-29
Hydrates of andinotropic agent
ZA882478B
(en )
1989-12-27
New uses of dopamine receptor agonists
IE862857L
(en )
1987-04-30
INHIBITORS OF DOPAMINE ß-HYDROXYLASE
IE852617L
(en )
1986-04-24
Occular formulation comprising bromocriptine
IL78040A0
(en )
1986-07-31
Use of(-)-15-deoxyspergualine as an immunosuppressor